These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23486500)

  • 1. Chlamydia trachomatis infection among women 26 to 39 years of age in the United States, 1999 to 2010.
    Torrone EA; Geisler WM; Gift TL; Weinstock HS
    Sex Transm Dis; 2013 Apr; 40(4):335-7. PubMed ID: 23486500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.
    Ditkowsky J; Shah KH; Hammerschlag MR; Kohlhoff S; Smith-Norowitz TA
    BMC Infect Dis; 2017 Feb; 17(1):155. PubMed ID: 28214469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia trachomatis infections in female military recruits.
    Gaydos CA; Howell MR; Pare B; Clark KL; Ellis DA; Hendrix RM; Gaydos JC; McKee KT; Quinn TC
    N Engl J Med; 1998 Sep; 339(11):739-44. PubMed ID: 9731090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
    Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
    Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.
    Nyári T; Nyári C; Woodward M; Mészáros G; Deák J; Nagy E; Kovács L
    Acta Obstet Gynecol Scand; 2001 Apr; 80(4):300-6. PubMed ID: 11264602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia trachomatis: common misperceptions and misunderstandings.
    Stevens-Simon C; Sheeder J
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):231-43. PubMed ID: 16171726
    [No Abstract]   [Full Text] [Related]  

  • 7. Should all sexually active young women in Hungary be screened for Chlamydia trachomatis?
    Nyári T; Woodward M; Kovács L
    Eur J Obstet Gynecol Reprod Biol; 2003 Jan; 106(1):55-9. PubMed ID: 12475582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for Chlamydia trachomatis infection in pregnant women in Martinique.
    Chout RT; Vaton S; Duval-Violton D; Leguyader-Despres P; Orfila J
    Sex Transm Dis; 1995; 22(4):221-7. PubMed ID: 7482104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Chlamydia trachomatis among young German adolescents, 2005-06.
    Desai S; Meyer T; Thamm M; Hamouda O; Bremer V
    Sex Health; 2011 Mar; 8(1):120-2. PubMed ID: 21371394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012.
    Torrone E; Papp J; Weinstock H;
    MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(38):834-8. PubMed ID: 25254560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures.
    Trebach JD; Chaulk CP; Page KR; Tuddenham S; Ghanem KG
    Sex Transm Dis; 2015 May; 42(5):233-9. PubMed ID: 25868133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics.
    Humphreys JT; Henneberry JF; Rickard RS; Beebe JL
    Sex Transm Dis; 1992; 19(1):47-53. PubMed ID: 1561588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific chlamydial infection among pregnant women in the United States: evidence for updated recommendations.
    Tao G; Hoover KW; Nye MB; Body BA
    Sex Transm Dis; 2014 Sep; 41(9):556-9. PubMed ID: 25118971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective screening for Chlamydia trachomatis infection in nonurban family planning clinics in Wisconsin.
    Addiss DG; Vaughn ML; Holzhueter MA; Bakken LL; Davis JP
    Fam Plann Perspect; 1987; 19(6):252-6. PubMed ID: 3436412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The silent epidemic of Chlamydia trachomatis: the urgent need for detection and treatment in women.
    Walsh C; Anderson LA; Irwin K
    J Womens Health Gend Based Med; 2000 May; 9(4):339-43. PubMed ID: 10868604
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.
    Rours GI; Smith-Norowitz TA; Ditkowsky J; Hammerschlag MR; Verkooyen RP; de Groot R; Verbrugh HA; Postma MJ
    Pathog Glob Health; 2016; 110(7-8):292-302. PubMed ID: 27958189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported Chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008.
    Tao G; Hoover KW; Leichliter JS; Peterman TA; Kent CK
    Sex Transm Dis; 2012 Aug; 39(8):605-7. PubMed ID: 22801342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of regular chlamydia testing by U.S. women: a longitudinal study.
    Heijne JC; Tao G; Kent CK; Low N
    Am J Prev Med; 2010 Sep; 39(3):243-50. PubMed ID: 20709256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.